BioCentury
ARTICLE | Financial News

Aquestive gets modest pop after $67.5M IPO

July 25, 2018 7:06 PM UTC

Aquestive Therapeutics Inc. (NASDAQ:AQST) was up $1.05 to $16.05 in afternoon trading Wednesday after raising $67.5 million through the sale of 4.5 million shares at $15 in an upsized IPO. Underwriters were BMO Capital Markets, RBC Capital Markets, Wedbush PacGrow and JMP Securities.

Aquestive priced its offering in the middle of its proposed range of $14-$16. Last week, the company had hoped to sell 4 million shares...

BCIQ Company Profiles

Aquestive Therapeutics Inc.